Tissue Regenix Group PLC Result of AGM (7644A)
June 03 2021 - 7:37AM
UK Regulatory
TIDMTRX
RNS Number : 7644A
Tissue Regenix Group PLC
03 June 2021
Tissue Regenix Group plc
("Tissue Regenix" or "the Group")
Result of AGM
Tissue Regenix (AIM: TRX), the regenerative medical devices
company, announces that at the AGM held earlier today, all
resolutions were duly passed.
The results of the poll are set out below:
Resolution In favour % Against % Withheld
1 Ordinary 3,399,235,541 100 0 0 546,855
--------- -------------- ----------- ----- ----------
2 Ordinary 3,399,212,980 99.99 76,421 0.01 569,416
--------- -------------- ----------- ----- ----------
3 Ordinary 3,399,212,980 99.99 76,421 0.01 569,416
--------- -------------- ----------- ----- ----------
4 Ordinary 3,399,656,835 99.99 16,274 0.01 125,561
--------- -------------- ----------- ----- ----------
5 Ordinary 3,399,656,835 99.99 74,846 0.01 125,561
--------- -------------- ----------- ----- ----------
6 Ordinary 3,399,656,835 99.99 16,274 0.01 125,561
--------- -------------- ----------- ----- ----------
7 Ordinary 3,399,656,835 99.99 17,849 0.01 125,561
--------- -------------- ----------- ----- ----------
8 Ordinary 3,399,338,541 99.99 194,449 0.01 443,855
--------- -------------- ----------- ----- ----------
9 Ordinary 3,399,338,541 99.99 17,849 0.01 443,855
--------- -------------- ----------- ----- ----------
10 Ordinary 3,397,632,396 99.90 3,420,838 0.10 2,150,000
--------- -------------- ----------- ----- ----------
11 Special 3,397,632,396 99.31 23,283,587 0.69 2,150,000
--------- -------------- ----------- ----- ----------
12 Special 3,399,782,396 99.88 4,162,711 0.12 0
--------- -------------- ----------- ----- ----------
NB: Percentage of Votes cast excludes Withheld votes
The full text of the resolutions passed at the AGM may be found
in the Notice of AGM published on 28 April 2021.
For more information:
Tissue Regenix Group plc www.tissueregenix.com
David Cocke, Chief Financial Officer Via Walbrook PR
Stifel Nicolaus Europe Limited (Nominated Adviser Tel: +44(0)20 7710 7600
and Broker)
Ben Maddison / Alex Price
Walbrook PR Ltd Tel: +44 (0)20 7933 8780
Alice Woodings / Paul McManus TissueRegenix@walbrookpr.com
About Tissue Regenix ( www.tissueregenix.com )
Tissue Regenix is a leading medical devices company in the field
of regenerative medicine. The company's patented decellularisation
('dCELL(R)') technology removes DNA and other cellular material
from animal and human soft tissue leaving an acellular tissue
scaffold which is not rejected by the patient's body and can then
be used to repair diseased or worn-out body parts. Current
applications address many critical clinical needs such as sports
medicine, heart valve replacement and wound care.
In August 2017 Tissue Regenix acquired CellRight
Technologies(R), a biotech company that specializes in regenerative
medicine and is dedicated to the development of innovative
osteoinductive and soft tissue scaffolds that enhance healing
opportunities of defects created by trauma and disease. CellRight's
human osteobiologics may be used in spine, trauma, general
orthopaedic, foot & ankle, dental, and sports medicine surgical
procedures.
The information contained in this notification is disclosed in
accordance with the requirements of the EU Market Abuse Regulation
as it forms part of UK law by virtue of the European Union
(Withdrawal) Act 2018. The notification form is set out below.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGSSDFEDEFSEDM
(END) Dow Jones Newswires
June 03, 2021 08:37 ET (12:37 GMT)
Tissue Regenix (LSE:TRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tissue Regenix (LSE:TRX)
Historical Stock Chart
From Apr 2023 to Apr 2024